학술논문

Hepatocellular Carcinoma and Congenital Absence of the Portal Vein in a Child Receiving Growth Hormone Therapy for Turner Syndrome
Document Type
Academic Journal
Source
Seminars in Liver Disease. Nov 01, 2007 27(4):427-431
Subject
Language
English
ISSN
0272-8087
Abstract
Turner syndrome patients are reported to have no increase in the relative risk of cancer, and hepatocellular carcinoma in particular has never been reported in this syndrome. However, Turner syndrome patients are known to have an increased prevalence of liver lesions, some of which, like focal nodular hyperplasia, are related to vascular anomalies. We report the case of a young patient with Turner syndrome, treated with recombinant human growth hormone, who was found to have absence of the portal vein, focal nodular hyperplasia, and hepatic adenoma and who developed a large hepatocellular carcinoma requiring liver transplant.